David Traver - Publications

2000 Stanford University, Palo Alto, CA 

7 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2009 Jaiswal S, Jamieson CH, Pang WW, Park CY, Chao MP, Majeti R, Traver D, van Rooijen N, Weissman IL. CD47 is upregulated on circulating hematopoietic stem cells and leukemia cells to avoid phagocytosis. Cell. 138: 271-85. PMID 19632178 DOI: 10.1016/j.cell.2009.05.046  0.4
2005 Akashi K, Traver D, Zon LI. The complex cartography of stem cell commitment. Cell. 121: 160-2. PMID 15851023 DOI: 10.1016/j.cell.2005.04.005  0.4
2004 Shigematsu H, Reizis B, Iwasaki H, Mizuno S, Hu D, Traver D, Leder P, Sakaguchi N, Akashi K. Plasmacytoid dendritic cells activate lymphoid-specific genetic programs irrespective of their cellular origin. Immunity. 21: 43-53. PMID 15345219 DOI: 10.1016/j.immuni.2004.06.011  0.4
2004 Traver D, Akashi K. Lineage commitment and developmental plasticity in early lymphoid progenitor subsets. Advances in Immunology. 83: 1-54. PMID 15135627 DOI: 10.1016/S0065-2776(04)83001-3  0.4
2003 Jaiswal S, Traver D, Miyamoto T, Akashi K, Lagasse E, Weissman IL. Expression of BCR/ABL and BCL-2 in myeloid progenitors leads to myeloid leukemias. Proceedings of the National Academy of Sciences of the United States of America. 100: 10002-7. PMID 12890867 DOI: 10.1073/pnas.1633833100  0.4
2002 BitMansour A, Burns SM, Traver D, Akashi K, Contag CH, Weissman IL, Brown JM. Myeloid progenitors protect against invasive aspergillosis and Pseudomonas aeruginosa infection following hematopoietic stem cell transplantation. Blood. 100: 4660-7. PMID 12393415 DOI: 10.1182/blood-2002-05-1552  0.4
2002 Na Nakorn T, Traver D, Weissman IL, Akashi K. Myeloerythroid-restricted progenitors are sufficient to confer radioprotection and provide the majority of day 8 CFU-S. The Journal of Clinical Investigation. 109: 1579-85. PMID 12070305 DOI: 10.1172/JCI15272  0.4
Show low-probability matches.